Alinity I transplant assay
Device
Abbott Laboratories
Total Payments
$162,711
Transactions
14
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $162,711 | 14 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $162,711 | 14 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Alinity I Transplant Assay Clinical Evaluation | Abbott Laboratories | $160,653 | 0 |
| Alinity I Transplant Assay Clinical Evaluation Protocol | Abbott Laboratories | $2,058 | 0 |
Top Doctors Receiving Payments for Alinity I transplant assay
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Falls Church, VA | $162,711 | 14 |
Ad
Manufacturing Companies
- Abbott Laboratories $162,711
Product Information
- Type Device
- Total Payments $162,711
- Total Doctors 0
- Transactions 14
About Alinity I transplant assay
Alinity I transplant assay is a device associated with $162,711 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $162,711 was paid across 14 transactions to 0 doctors.
The most common payment nature for Alinity I transplant assay is "Unspecified" ($162,711, 100.0% of total).
Alinity I transplant assay is associated with 2 research studies, including "Alinity I Transplant Assay Clinical Evaluation" ($160,653).